What is HeartLab?
HeartLab provides a comprehensive platform for echocardiograms, enabling healthcare professionals to analyze ultrasound images for diagnosing cardiovascular disease. The company's software not only aids in image interpretation but also streamlines the generation of patient reports, integrating seamlessly into electronic health records. Founded in 2018 and based in Auckland, New Zealand, HeartLab is positioned at the intersection of medical imaging technology and digital health, aiming to improve diagnostic accuracy and operational efficiency in cardiology.
How much funding has HeartLab raised?
HeartLab has raised a total of $3.3M across 2 funding rounds:
Angel/Seed
$800K
Angel/Seed
$2.5M
Angel/Seed (2020): $800K with participation from Icehouse Ventures and Founders Fund
Angel/Seed (2021): $2.5M led by Outset Ventures, Icehouse Ventures, and Founders Fund
Key Investors in HeartLab
Icehouse Ventures
Icehouse Ventures is a New Zealand-based venture capital firm that has evolved from NZ's first angel network. With $250 million in assets under management, they focus on early-stage ventures and support Kiwi innovators with a global outlook.
Founders Fund
Founders Fund is a prominent venture capital firm known for investing in transformative companies across various sectors and stages. Their partners have a track record of backing successful tech giants, indicating a strategic focus on high-growth potential.
Outset Ventures
Outset Ventures is a New Zealand-based deep tech venture fund and incubator that supports the development of global enterprises. They are known for fostering innovative companies, particularly in the deep technology space.
What's next for HeartLab?
The recent major strategic investment signals a pivotal phase for HeartLab, likely enabling the company to scale its operations, enhance its technological capabilities, and expand its market reach. This capital infusion is expected to accelerate product development, potentially incorporating further AI advancements for predictive diagnostics and expanding its footprint in global healthcare markets. The company's focus on streamlining diagnostic workflows and improving patient outcomes positions it for continued growth and impact in the cardiovascular health sector.
See full HeartLab company page
